Login
| TI Ref No : | 519220050 |
|---|---|
| Description : | A: Lenalidomide Hydrate 5 Mg X 40 Capsules/box 500 Boxes, B: Labrizumab (genetic Recombination) Injection Solution 300 Mg 3 Ml/bottle 900 Bottles, C: Labrizumab (genetic Recombination) Injection Solution 1,100 Mg 11 Ml/bottle 120 Bottles, D: Butoliciranna |
| Date : | 2025-06-16 |
| Deadline : | 2025-08-15 |
| Document Type : | Tenders |
